1. Home
  2. Labeler Index
  3. Remedyrepack Inc.
  4. 70518-2725
  5. NDC Package Code: 70518-2725-0 Naloxone Hydrochloride

NDC Package 70518-2725-0 Naloxone Hydrochloride

Injection Parenteral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70518-2725-0
Package Description:
10 SYRINGE in 1 BOX / 2 mL in 1 SYRINGE (70518-2725-1)
Product Code:
70518-2725
Proprietary Name:
Naloxone Hydrochloride
Non-Proprietary Name:
Naloxone Hydrochloride
Substance Name:
Naloxone Hydrochloride
Usage Information:
Naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including, propoxyphene, methadone and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine and butorphanol and cyclazocine. Naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage.Naloxone hydrochloride injection may be useful as an adjunctive agent to increase blood pressure in the management of septic shock. (see CLINICAL PHARMACOLOGY; Adjunctive Use in Septic Shock).
11-Digit NDC Billing Format:
70518272500
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Remedyrepack Inc.
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s):
Parenteral - Administration by injection, infusion, or implantation.
Active Ingredient(s):
NALOXONE HYDROCHLORIDE 1 mg/mL
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA072076
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
05-05-2020
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70518-2725-0?

The NDC Packaged Code 70518-2725-0 is assigned to a package of 10 syringe in 1 box / 2 ml in 1 syringe (70518-2725-1) of Naloxone Hydrochloride, a human prescription drug labeled by Remedyrepack Inc.. The product's dosage form is injection and is administered via parenteral form.

Is NDC 70518-2725 included in the NDC Directory?

Yes, Naloxone Hydrochloride with product code 70518-2725 is active and included in the NDC Directory. The product was first marketed by Remedyrepack Inc. on May 05, 2020 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 70518-2725-0?

The 11-digit format is 70518272500. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-170518-2725-05-4-270518-2725-00